REVVITY, INC Unamortized Debt Issuance Expense
REVVITY, INC (RVTY) had Unamortized Debt Issuance Expense of $14.88 million as of 2026-07-05, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:UnamortizedDebtIssuanceExpense · last filed 2026-08-11
- 2026-07-05: Unamortized Debt Issuance Expense $14.88M.
- 2026-04-05: Unamortized Debt Issuance Expense $15.88M.
- 2025-12-28: Unamortized Debt Issuance Expense $16.73M.
- 2025-09-28: Unamortized Debt Issuance Expense $17.47M.
| Period end | Unamortized Debt Issuance Expense |
|---|---|
| 2026-07-05 | $14.88M 10-Q · filed 2026-08-11 |
| 2026-04-05 | $15.88M 10-Q · filed 2026-05-12 |
| 2025-12-28 | $16.73M 10-K · filed 2026-02-24 |
| 2025-09-28 | $17.47M 10-Q · filed 2025-11-04 |
| 2025-06-29 | $18.42M 10-Q · filed 2025-08-05 |
| 2025-03-30 | $19.34M 10-Q · filed 2025-05-06 |
| 2024-12-29 | $17.82M 10-K · filed 2026-02-24 |
| 2024-09-29 | $18.58M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $19.87M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $21.31M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $22.71M 10-K · filed 2025-02-25 |
| 2023-10-01 | $23.98M 10-Q · filed 2023-11-07 |
| 2023-07-02 | $25.63M 10-Q · filed 2023-08-09 |
| 2023-04-02 | $27.32M 10-Q · filed 2023-05-12 |
| 2023-01-01 | $28.82M 10-K · filed 2024-02-27 |
| 2022-10-02 | $30.14M 10-Q · filed 2022-11-14 |
| 2022-07-03 | $32.03M 10-Q · filed 2022-08-09 |
| 2022-04-03 | $34.16M 10-Q · filed 2022-05-10 |
| 2022-01-02 | $35.78M 10-K · filed 2023-03-01 |
| 2021-10-03 | $40.12M 10-Q · filed 2021-11-09 |
| 2021-07-04 | $19.46M 10-Q · filed 2021-08-10 |
| 2021-01-03 | $12.54M 10-K · filed 2022-03-03 |
| 2014-12-28 | $6.50M 10-K · filed 2016-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |